MME and non-small cell lung carcinoma: In order to address the maturation status of LDNs in our study cohort, we analyzed the expression of some myeloid and maturation markers including CD10, CD16, CD15 and CD11b in the LDN and HDN fractions of 7 NSCLC patients (Supplementary Figure 4A).